About Jwalant Shukla
Form D filings for Nivagen Pharmaceuticals from 2017 to 2023 list Jwalant Shukla as CEO and director.
Jwalant Shukla first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Jwalant Shukla in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jwalant Shukla works with at each company, as listed on that company's latest Form D.
Nivagen Pharmaceuticals, Inc. · Form D, Aug 11, 2023
DL
Dasaradhi Lakkaraju
Executive officer
JM
Jaswinder Matharu
Director
GP
Gopal Patel
Executive officer
RH
Rob Hart
Director
AS
Ashish Sevak
Director
PD
Praneel Deo
Executive officer
MK
Michael Kulper
Director